[go: up one dir, main page]

GB0311688D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0311688D0
GB0311688D0 GB0311688A GB0311688A GB0311688D0 GB 0311688 D0 GB0311688 D0 GB 0311688D0 GB 0311688 A GB0311688 A GB 0311688A GB 0311688 A GB0311688 A GB 0311688A GB 0311688 D0 GB0311688 D0 GB 0311688D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0311688A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0311688A priority Critical patent/GB0311688D0/en
Publication of GB0311688D0 publication Critical patent/GB0311688D0/en
Priority to TW093113762A priority patent/TWI328009B/en
Priority to US10/557,079 priority patent/US7566786B2/en
Priority to CN2004800206511A priority patent/CN1823063B/en
Priority to NZ543554A priority patent/NZ543554A/en
Priority to ES08152215T priority patent/ES2374850T3/en
Priority to KR1020057022135A priority patent/KR101144548B1/en
Priority to ES04733799T priority patent/ES2301993T3/en
Priority to PCT/EP2004/005494 priority patent/WO2004103998A1/en
Priority to DK04733799T priority patent/DK1633748T3/en
Priority to PL04733799T priority patent/PL1633748T3/en
Priority to DE602004012260T priority patent/DE602004012260T2/en
Priority to AU2004240759A priority patent/AU2004240759B2/en
Priority to AT08152215T priority patent/ATE529421T1/en
Priority to PT04733799T priority patent/PT1633748E/en
Priority to MXPA05012466A priority patent/MXPA05012466A/en
Priority to PL08152215T priority patent/PL1944305T3/en
Priority to CA2526228A priority patent/CA2526228C/en
Priority to SI200430691T priority patent/SI1633748T1/en
Priority to SI200431802T priority patent/SI1944305T1/en
Priority to AT04733799T priority patent/ATE388148T1/en
Priority to EP08152215A priority patent/EP1944305B1/en
Priority to EP04733799A priority patent/EP1633748B1/en
Priority to PT08152215T priority patent/PT1944305E/en
Priority to RU2005135016/04A priority patent/RU2335493C2/en
Priority to DK08152215.3T priority patent/DK1944305T3/en
Priority to JP2006529889A priority patent/JP4625460B2/en
Priority to BRPI0410477-3A priority patent/BRPI0410477A/en
Priority to ARP040101734A priority patent/AR044401A1/en
Priority to IS8110A priority patent/IS2581B/en
Priority to IL171726A priority patent/IL171726A/en
Priority to EGNA2005000730 priority patent/EG24774A/en
Priority to CO05116284A priority patent/CO5700780A2/en
Priority to NO20055421A priority patent/NO330754B1/en
Priority to ZA200509319A priority patent/ZA200509319B/en
Priority to MA28611A priority patent/MA27808A1/en
Priority to US11/349,701 priority patent/US20070049570A1/en
Priority to US11/349,677 priority patent/US7572915B2/en
Priority to HK06109975A priority patent/HK1092458A1/en
Priority to CY20081100534T priority patent/CY1108094T1/en
Priority to HR20080236T priority patent/HRP20080236T3/en
Priority to HK08109372.1A priority patent/HK1118274A1/en
Priority to US12/474,324 priority patent/US20090312325A1/en
Priority to HR20110957T priority patent/HRP20110957T1/en
Priority to CY20121100032T priority patent/CY1112232T1/en
Ceased legal-status Critical Current

Links

GB0311688A 2003-05-21 2003-05-21 Compounds Ceased GB0311688D0 (en)

Priority Applications (45)

Application Number Priority Date Filing Date Title
GB0311688A GB0311688D0 (en) 2003-05-21 2003-05-21 Compounds
TW093113762A TWI328009B (en) 2003-05-21 2004-05-14 Quinoline derivatives as phosphodiesterase inhibitors
ARP040101734A AR044401A1 (en) 2003-05-21 2004-05-19 COMPOUNDS DERIVED FROM QUINOLEINA, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR EMPLOYMENT IN THE MANUFACTURE OF MEDICINES.
PT08152215T PT1944305E (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
CN2004800206511A CN1823063B (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
NZ543554A NZ543554A (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
ES08152215T ES2374850T3 (en) 2003-05-21 2004-05-19 DERIVATIVES OF QUINOLINA AS PHOSPHODIESTERASE INHIBITORS.
KR1020057022135A KR101144548B1 (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
ES04733799T ES2301993T3 (en) 2003-05-21 2004-05-19 DERIVATIVES OF QUINOLINA AS PHOSPHODIESTERASE INHIBITORS.
PCT/EP2004/005494 WO2004103998A1 (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
DK04733799T DK1633748T3 (en) 2003-05-21 2004-05-19 Quinoline-free fatty acid phosphodiesterase inhibitors
PL04733799T PL1633748T3 (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
DE602004012260T DE602004012260T2 (en) 2003-05-21 2004-05-19 CHINOLINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS
AU2004240759A AU2004240759B2 (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
AT08152215T ATE529421T1 (en) 2003-05-21 2004-05-19 QUINOLINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS
PT04733799T PT1633748E (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
MXPA05012466A MXPA05012466A (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors.
PL08152215T PL1944305T3 (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
CA2526228A CA2526228C (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
SI200430691T SI1633748T1 (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
SI200431802T SI1944305T1 (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
AT04733799T ATE388148T1 (en) 2003-05-21 2004-05-19 QUINOLINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS
EP08152215A EP1944305B1 (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
US10/557,079 US7566786B2 (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
RU2005135016/04A RU2335493C2 (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
EP04733799A EP1633748B1 (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
DK08152215.3T DK1944305T3 (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
JP2006529889A JP4625460B2 (en) 2003-05-21 2004-05-19 Quinoline derivatives as phosphodiesterase inhibitors
BRPI0410477-3A BRPI0410477A (en) 2003-05-21 2004-05-19 compound or a pharmaceutically acceptable salt thereof, method for the prophylaxis or treatment of a chiral condition in a mammal, pharmaceutical formulation, combination, use of a compound, and process for preparing a compound
IS8110A IS2581B (en) 2003-05-21 2005-10-31 Quinoline derivatives inhibited by phosphodiesterase
IL171726A IL171726A (en) 2003-05-21 2005-11-02 Quinoline derivatives , their use in the manufacture of medicaments for the prophylaxis or treatment of a clinical condition for which a selective pde4 inhibitor is indicated, their preparation and pharmaceutical compositions comprising them
EGNA2005000730 EG24774A (en) 2003-05-21 2005-11-15 Quinoline derivatives as phosphodiesterase inhibitors.
CO05116284A CO5700780A2 (en) 2003-05-21 2005-11-16 DERIVATIVES OF QUINOLINA AS INHIBITORS, SELECTIVE, OF PHOSPHODIESTERASE PDE 4B
NO20055421A NO330754B1 (en) 2003-05-21 2005-11-16 Quinoline derivatives, processes for the preparation of such, pharmaceutical formulations comprising such, such compounds in medical therapy, and such compounds for the treatment of disease
ZA200509319A ZA200509319B (en) 2003-05-21 2005-11-17 Quinoline derivatives as phosphodiesterase inhibitors
MA28611A MA27808A1 (en) 2003-05-21 2005-11-21 QUINOLINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE
US11/349,701 US20070049570A1 (en) 2003-05-21 2006-02-08 Quinoline derivatives as phosphodiesterase inhibitors
US11/349,677 US7572915B2 (en) 2003-05-21 2006-02-08 Quinoline derivatives as phosphodiesterase inhibitors
HK06109975A HK1092458A1 (en) 2003-05-21 2006-09-07 Quinoline derivatives as phosphodiesterase inhibitors
CY20081100534T CY1108094T1 (en) 2003-05-21 2008-05-23 KINOLIN PRODUCTS AS PHOSPHOSTERATION INFLUENCES
HR20080236T HRP20080236T3 (en) 2003-05-21 2008-05-29 Quinoline derivatives as phosphodiesterase inhibitors
HK08109372.1A HK1118274A1 (en) 2003-05-21 2008-08-21 Quinoline derivatives as phosphodiesterase inhibitors
US12/474,324 US20090312325A1 (en) 2003-05-21 2009-05-29 Quinoline Derivatives As Phosphodiesterase Inhibitors
HR20110957T HRP20110957T1 (en) 2003-05-21 2011-12-20 Quinoline derivatives as phosphodiesterase inhibitors
CY20121100032T CY1112232T1 (en) 2003-05-21 2012-01-11 KINOLIN PRODUCTS AS PHOSPHOSTERATION INHIBITORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0311688A GB0311688D0 (en) 2003-05-21 2003-05-21 Compounds

Publications (1)

Publication Number Publication Date
GB0311688D0 true GB0311688D0 (en) 2003-06-25

Family

ID=9958506

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0311688A Ceased GB0311688D0 (en) 2003-05-21 2003-05-21 Compounds

Country Status (1)

Country Link
GB (1) GB0311688D0 (en)

Similar Documents

Publication Publication Date Title
GB0316915D0 (en) Compounds
GB0309781D0 (en) Compounds
GB0315950D0 (en) Compounds
GB0305559D0 (en) Compounds
GB0317268D0 (en) Compounds
GB0314476D0 (en) Compounds
GB0314479D0 (en) Compounds
GB0314478D0 (en) Compounds
EP1689403A4 (en) Heteroaryl-hydrazone compounds
GB0304665D0 (en) Compounds
GB0317498D0 (en) Compounds
GB0305553D0 (en) Compounds
GB0313915D0 (en) Compounds
GB0306329D0 (en) Compounds
GB0313914D0 (en) Compounds
EP1682514A4 (en) 11- o-methylgeldanamycin compounds
GB0304494D0 (en) Compounds
GB0302512D0 (en) Compounds
GB0317269D0 (en) Compounds
GB0310890D0 (en) Glycopeptidic compounds
GB0313360D0 (en) Compounds
GB0307998D0 (en) Compounds
GB0308017D0 (en) Compounds
GB0308105D0 (en) Compounds
GB0309326D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)